Alina Gerrie
Alina Gerrie
Assistant Professor, University of British Columbia
Verified email at
TitleCited byYear
Fludarabine and rituximab for relapsed or refractory hairy cell leukemia
AS Gerrie, LN Zypchen, JM Connors
Blood 119 (9), 1988-1991, 2012
D (T) PACE as salvage therapy for aggressive or refractory multiple myeloma
AS Gerrie, JR Mikhael, L Cheng, H Jiang, V Kukreti, T Panzarella, ...
British journal of haematology 161 (6), 802-810, 2013
Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma
AS Gerrie, MM Power, JD Shepherd, KJ Savage, LH Sehn, JM Connors
Annals of oncology 25 (11), 2218-2223, 2014
Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia
KH Xing, A Kahlon, BF Skinnider, JM Connors, RD Gascoyne, LH Sehn, ...
British journal of haematology 169 (4), 520-527, 2015
Outcome of patients with non-Hodgkin lymphomas with concurrent MYC and BCL2 rearrangements treated with CODOX-M/IVAC with rituximab followed by hematopoietic stem cell …
H Sun, KJ Savage, A Karsan, GW Slack, RD Gascoyne, CL Toze, ...
Clinical Lymphoma Myeloma and Leukemia 15 (6), 341-348, 2015
Rituximab with high‐dose methotrexate in primary central nervous system lymphoma
R Kansara, TN Shenkier, JM Connors, LH Sehn, KJ Savage, AS Gerrie, ...
American journal of hematology 90 (12), 1149-1154, 2015
Phase 2 trial of interim PET scan-tailored therapy in patients with advanced stage diffuse large B-cell lymphoma (DLBCL) in British Columbia (BC)
LH Sehn, ELG Hardy, KK Gill, AJ Al-Tourah, J Shustik, NA Macpherson, ...
Blood 124 (21), 392-392, 2014
Observation as the initial management strategy in patients with mantle cell lymphoma
P Abrisqueta, DW Scott, GW Slack, C Steidl, A Mottok, RD Gascoyne, ...
Annals of Oncology 28 (10), 2489-2495, 2017
Diffuse large B‐cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era
R Kridel, D Telio, D Villa, LH Sehn, AS Gerrie, T Shenkier, R Klasa, ...
British journal of haematology 176 (2), 210-221, 2017
Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trials
AS Gerrie, CL Toze, KM Ramadan, CH Li, J Sutherland, A Yee, ...
Leukemia & lymphoma 53 (1), 77-82, 2012
Evaluation of the risk of relapse in classical Hodgkin lymphoma at event-free survival time points and survival comparison with the general population in British Columbia
G Hapgood, Y Zheng, LH Sehn, D Villa, R Klasa, AS Gerrie, T Shenkier, ...
Journal of Clinical Oncology 34 (21), 2493-2500, 2016
Preservation of lower incidence of chronic lymphocytic leukemia in Chinese residents in British Columbia: a 26-year survey from 1983 to 2008
V Mak, D Ip, O Mang, C Dalal, S Huang, A Gerrie, T Gillan, KM Ramadan, ...
Leukemia & lymphoma 55 (4), 824-827, 2014
Advanced stage classical Hodgkin lymphoma patients with a negative PET-scan following treatment with ABVD have excellent outcomes without the need for consolidative …
KJ Savage, JM Connors, DR Villa, G Hapgood, AS Gerrie, TN Shenkier, ...
Blood 126 (23), 579-579, 2015
Outcome of patients with double-hit lymphomas treated with CODOX-M/IVAC+ R followed by hematopoietic stem cell transplantation in British Columbia
KJ Savage, A Karsan, GW Slack, CL Toze, LH Sehn, YRA Mourad, ...
Blood 122 (21), 1788-1788, 2013
I gG4‐related disease with hypergammaglobulinemic hyperviscosity and retinopathy
PCW Wong, AT Fung, AS Gerrie, G Moloney, D Maberley, D Rossman, ...
European journal of haematology 90 (3), 250-256, 2013
Allogeneic hematopoietic stem cell transplantation is an effective salvage therapy for patients with chronic myeloid leukemia presenting with advanced disease or failing …
AP Nair, MJ Barnett, RC Broady, DE Hogge, KW Song, CL Toze, ...
Biology of Blood and Marrow Transplantation 21 (8), 1437-1444, 2015
Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British Columbia
B Lee, O Goktepe, K Hay, JM Connors, LH Sehn, KJ Savage, T Shenkier, ...
The oncologist 19 (3), 283-290, 2014
Prognostic model to predict post-autologous stem-cell transplantation outcomes in classical Hodgkin lymphoma
FC Chan, A Mottok, AS Gerrie, M Power, M Nijland, A Diepstra, ...
J Clin Oncol 35 (32), 3722-3733, 2017
Site of central nervous system (CNS) relapse in patients with diffuse large B‐cell lymphoma (DLBCL) by the CNS‐IPI risk model
R Kansara, D Villa, AS Gerrie, R Klasa, T Shenkier, DW Scott, GW Slack, ...
British journal of haematology 179 (3), 508-510, 2017
Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphoma
K Hay, B Lee, O Goktepe, JM Connors, LH Sehn, KJ Savage, R Klasa, ...
Leukemia & lymphoma 57 (2), 276-282, 2016
The system can't perform the operation now. Try again later.
Articles 1–20